Assignee
VENATORX PHARMACEUTICALS INC
US·40 granted patents·16 pending applications·373 citations·filing 2013–2025
Top patents by PatentIndex Score
56 records- 0198US9511142B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·50 cites·19 claims
- 0297US11638715B2Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2022·Granted May 2, 2023·9 cites·30 claims
- 0396US10669290B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 2, 2020·8 cites·18 claims
- 0496US9783555B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Oct 10, 2017·15 cites·20 claims
- 0596US9376454B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Jun 28, 2016·24 cites·20 claims
- 0696US9040504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·34 cites·18 claims
- 0796US8912169B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·34 cites·20 claims
- 0895US9828391B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·15 cites·16 claims
- 0995US9802966B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·10 cites·20 claims
- 1095US9637504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted May 2, 2017·19 cites·18 claims
- 1195US9403850B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·25 cites·20 claims
- 1294US10294248B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted May 21, 2019·7 cites·20 claims
- 1394US10214547B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Feb 26, 2019·10 cites·10 claims
- 1494US9771382B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 26, 2017·15 cites·19 claims
- 1594US9422314B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·22 cites·21 claims
- 1693US11566001B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·2 cites·11 claims
- 1793US9944658B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Apr 17, 2018·10 cites·19 claims
- 1893US9926336B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Mar 27, 2018·12 cites·20 claims
- 1992US10590076B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Mar 17, 2020·6 cites·17 claims
- 2092US10294247B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·20 claims
- 2191US11008346B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted May 18, 2021·2 cites·20 claims
- 2291US10125152B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Nov 13, 2018·8 cites·20 claims
- 2390US11091505B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Aug 17, 2021·4 cites·19 claims
- 2489US10889600B2Boron-containing compoundsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Jan 12, 2021·7 cites·15 claims
- 2589US2025236632A1Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2688US11560392B2Boron-containing compoundsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted Jan 24, 2023·2 cites·1 claims
- 2787US11820784B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Nov 21, 2023·1 cites·20 claims
- 2887US10399996B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 3, 2019·6 cites·17 claims
- 2984US12187752B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Jan 7, 2025·0 cites·15 claims
- 3084US10464952B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·5 cites·13 claims
- 3183US11267826B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Mar 8, 2022·2 cites·20 claims
- 3283US2025320235A1Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3381US11046716B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 29, 2021·1 cites·20 claims
- 3479US11014881B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted May 25, 2021·1 cites·17 claims
- 3577US2023062975A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3672US12102648B2Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Oct 1, 2024·0 cites·19 claims
- 3770US11414435B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 3870US11247965B2Hepatitis B capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Feb 15, 2022·1 cites·18 claims
- 3963US2025228882A1Orally-bioavailable nucleoside analogsVENATORX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4060US12559509B1Citrate coordination complex of an orally-delivered beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2025·Granted Feb 24, 2026·0 cites·22 claims
- 4158US2024270762A1Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4257US2024018166A1Sulfonyl urea nlrp3 inflammasome inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4355US12084445B2Broad-spectrum carbapenemsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Sep 10, 2024·0 cites·12 claims
- 4455US2017145037A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4553US12544395B2Combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Feb 10, 2026·0 cites·34 claims
- 4653US2023127898A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4752US2023107941A1Hepatitis b capsid assembly modulatorsVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4851US2023114728A1Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4951US2023127944A1Broad-spectrum carbapenemsVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 5051US2015361108A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when VENATORX PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →